Evidence map›Paper›PMID 32362642›Full record

ReviewThe Indian journal of medical research

The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence.

Pranab Chatterjee, Nazia Nagi, Anup Agarwal, Bhabatosh Das, Sayantan Banerjee, Swarup Sarkar, Nivedita Gupta, Raman R Gangakhedkar

Abstract readReview
In one paragraph

Review in The Indian journal of medical research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Safety of Endoscopy Units during the COVID-19 Pandemic.GE Portuguese journal of gastroenterology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Stigmatic Impact of COVID-19 Pandemic on Head & Neck Cancers Survivors.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Pranab ChatterjeeTranslational Global Health Policy Research Cell, Indian Council of Medical Research, New Delhi, India.
Nazia NagiDepartment of Microbiology, Maulana Azad Medical College, New Delhi, India.
Anup AgarwalTranslational Global Health Policy Research Cell, Indian Council of Medical Research, New Delhi, India.
Bhabatosh DasTranslational Health Science & Technology Institute, Pali, Haryana, India.
Sayantan BanerjeeWorld Health Organization, South-East Asia Regional Office, New Delhi, India.
Swarup SarkarTranslational Global Health Policy Research Cell; CG Pandit Chair (Medical), Indian Council of Medical Research, New Delhi, India.
Nivedita GuptaDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.
Raman R GangakhedkarDivision of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel coronavirus (nCoV) spillover event, with its epicenter in Wuhan, People's Republic of China, has emerged as a public health emergency of international concern. This began as an outbreak in December 2019, and till February 28, 2020, there have been 83,704 confirmed cases of novel coronavirus disease 2019 (COVID-19) globally, with 2,859 deaths, resulting in an overall case fatality rate of 3.41 per cent (95% confidence interval 3.29-3.54%). By this time (February 28, 2020) 58 countries or territories and one international conveyance (Diamond Princess Cruise Ship) were affected. As a part of the global response to manage and contain the pandemic, major emphasis was placed on generating research intelligence to guide evidence-based responses to contain the virus, which was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), owing to its genetic similarities with the SARS virus. This review summarizes the emerging evidence which can help guide the public health response, particularly in India. Key areas have been identified in which research needs to be conducted to generate critical intelligence for advising prevention and control efforts. The emergence of SARS-CoV-2 has once again exposed the weaknesses of global health systems preparedness, ability to respond to an infectious threat, the rapidity of transmission of infections across international borders and the ineffectiveness of knee-jerk policy responses to emerging/re-emerging infectious disease threats. The review concludes with the key learning points from the ongoing efforts to prevent and contain COVID-19 and identifies the need to invest in health systems, community-led response mechanisms and the need for preparedness and global health security.

Indexed as

BetacoronavirusCommunicable Disease ControlCoronavirus InfectionsCOVID-19Delivery of Health CareHumansIndiaPandemicsPneumonia, ViralPublic HealthSARS-CoV-2COVID-19epidemicMERS-CoVnovel coronaviruspandemicquarantinesevere acute respiratory syndrome coronavirus 2transmission

Identifiers

PMID32362642
PMCPMC7357405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.